======= ZNF217 ======= == Gene Information == * **Official Symbol**: ZNF217 * **Official Name**: zinc finger protein 217 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7764|7764]] * **UniProt**: [[https://www.uniprot.org/uniprot/O75362|O75362]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ZNF217&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZNF217|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602967|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Binds to the promoters of target genes and functions as repressor. Promotes cell proliferation and antagonizes cell death. Promotes phosphorylation of AKT1 at 'Ser-473'. {ECO:0000269|PubMed:16203743, ECO:0000269|PubMed:16940172, ECO:0000269|PubMed:17259635, ECO:0000269|PubMed:18625718}. No Pfam Domain information is available for this gene. |histone deacetylase complex| |transcription regulatory region DNA binding| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |nuclear speck| |RNA polymerase II proximal promoter sequence-specific DNA binding| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |DNA-binding transcription factor activity| |negative regulation of transcription by RNA polymerase II| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |mitochondrion| |organic cyclic compound biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |cellular nitrogen compound biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |negative regulation of gene expression| |macromolecule biosynthetic process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|-2.15| |[[:results:exp124|GSK343 3μM R03 exp124]]|-1.95| |[[:results:exp147|Resveratrol 16μM R03 exp147]]|-1.93| |[[:results:exp122|Golgicide-A 4μM R03 exp122]]|-1.84| |[[:results:exp262|Alda-1 10μM R06 exp262]]|1.74| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|1.77| |[[:results:exp405|Tenofovir 10μM R07 exp405]]|1.77| |[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|1.78| |[[:results:exp18|Doxycycline 10μM R00 exp18]]|1.79| |[[:results:exp285|GW501516 25μM R06 exp285]]|1.81| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|1.84| |[[:results:exp459|Bleomycin 5μM R08 exp459]]|1.89| |[[:results:exp414|Tozasertib 0.1μM R07 exp414]]|1.89| |[[:results:exp358|FK-506 5μM R07 exp358]]|1.91| |[[:results:exp349|Cytochalasin-B 5μM R07 exp349]]|2.13| |[[:results:exp463|Caffeine 2600μM R08 exp463]]|2.16| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|2.19| |[[:results:exp399|Salubrinal 20μM R07 exp399]]|2.23| |[[:results:exp497|Lead acetate 2000μM R08 exp497]]|2.25| |[[:results:exp443|SNS-032 15μM R08 exp443]]|2.29| |[[:results:exp333|All-trans-Retinoic-Acid 8μM R07 exp333]]|2.33| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|2.45| |[[:results:exp342|Calcium Ionophore 0.4μM R07 exp342]]|2.53| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|3.03| |[[:results:exp81|Selumetinib 20μM R02 exp81]]|3.15| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|5.37| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|5.45| ^Gene^Correlation^ |[[:human genes:t:tnfrsf10b|TNFRSF10B]]|0.426| |[[:human genes:i:ikzf2|IKZF2]]|0.424| |[[:human genes:c:creb1|CREB1]]|0.41| |[[:human genes:u:ube2e1|UBE2E1]]|0.406| |[[:human genes:f:fnip1|FNIP1]]|0.4| Global Fraction of Cell Lines Where Essential: 97/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|2/28| |blood|7/28| |bone|0/25| |breast|11/33| |central nervous system|2/56| |cervix|0/4| |colorectal|4/17| |esophagus|1/13| |fibroblast|0/1| |gastric|1/15| |kidney|2/21| |liver|4/20| |lung|8/75| |lymphocyte|0/14| |ovary|4/26| |pancreas|2/24| |peripheral nervous system|1/16| |plasma cell|11/15| |prostate|1/1| |skin|1/24| |soft tissue|1/7| |thyroid|1/2| |upper aerodigestive|0/22| |urinary tract|1/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2540 * **Expression level (log2 read counts)**: 7.29 {{:chemogenomics:nalm6 dist.png?nolink |}}